10,000 Shares in Cigna Group $CI Bought by RBF Capital LLC

Key Points

• RBF Capital LLC initiated a new position in Cigna Group, buying 10,000 shares worth about $2.75 million in the fourth quarter.
• Cigna reported strong quarterly results, with EPS of $7.79 beating estimates and revenue of $68.52 billion topping expectations; the company also reiterated FY 2026 guidance at 30.350 EPS.
• The company declared a quarterly dividend of $1.56 per share payable June 18, and analysts remain broadly positive with a Moderate Buy consensus and an average price target of $338.30.

RBF Capital LLC purchased a new position in shares of Cigna Group (NYSE:CI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,000 shares of the health services provider's stock, valued at approximately $2,752,000.

A number of other hedge funds have also recently added to or reduced their stakes in CI. Oddo BHF Asset Management Sas raised its position in Cigna Group by 28.8% during the fourth quarter. Oddo BHF Asset Management Sas now owns 12,115 shares of the health services provider's stock worth $3,334,000 after acquiring an additional 2,710 shares during the period. Rakuten Investment Management Inc. raised its position in Cigna Group by 16.4% during the fourth quarter. Rakuten Investment Management Inc. now owns 35,131 shares of the health services provider's stock worth $9,697,000 after acquiring an additional 4,955 shares during the period. Cynosure Group LLC acquired a new position in Cigna Group during the fourth quarter worth $400,000. 71 West Capital Partners acquired a new position in Cigna Group during the fourth quarter worth $291,000. Finally, William B. Walkup & Associates Inc. raised its position in Cigna Group by 51.8% during the fourth quarter. William B. Walkup & Associates Inc. now owns 475 shares of the health services provider's stock worth $131,000 after acquiring an additional 162 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Cigna Group stock opened at $292.01 on Wednesday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The stock has a market cap of $77.25 billion, a P/E ratio of 12.38, a PEG ratio of 1.13 and a beta of 0.28. The company has a 50-day moving average price of $283.44 and a 200 day moving average price of $278.26. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. During the same period last year, the business earned $6.74 earnings per share. Cigna Group's revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is presently 26.45%.

Analyst Upgrades and Downgrades

CI has been the subject of a number of research analyst reports. Mizuho upped their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Guggenheim upped their price objective on shares of Cigna Group from $334.00 to $338.00 and gave the stock a "buy" rating in a research report on Monday, May 4th. Morgan Stanley upped their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 20th. Jefferies Financial Group reduced their price objective on shares of Cigna Group from $333.00 to $330.00 and set a "buy" rating for the company in a research report on Monday, April 20th. Finally, Piper Sandler reduced their price objective on shares of Cigna Group from $370.00 to $346.00 and set an "overweight" rating for the company in a research report on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $338.30.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the firm's stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani sold 201,878 shares of the firm's stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company's stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.